Trials / Conditions / Locally Advanced Solid Tumors

Locally Advanced Solid Tumors

10 registered clinical trials studyying Locally Advanced Solid Tumors — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors NCT07050459	Jiangsu Simcere Pharmaceutical Co., Ltd.	Phase 1
Recruiting	A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combinati NCT06031441	Genentech, Inc.	Phase 1
Recruiting	A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations NCT04094610	Turning Point Therapeutics, Inc.	Phase 1 / Phase 2
Withdrawn	Imaging of Advanced Tumours Using [131]I-IAZA NCT03427320	University of Alberta	Phase 1 / Phase 2
Unknown	A Study of RX108 in Patients With Locally Advanced or Metastatic Solid Tumors NCT03646071	NeuPharma, Inc.	Phase 1
Terminated	This Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Me NCT03573544	OBI Pharma, Inc	Phase 1 / Phase 2
Recruiting	A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rea NCT03093116	Turning Point Therapeutics, Inc.	Phase 1 / Phase 2
Completed	A Phase 1 Study of INCMGA00012 in Patients With Advanced Solid Tumors NCT03059823	Incyte Corporation	Phase 1
Completed	Study of Oral RXDX-101 in Adult Patients With Locally Advanced or Metastatic Cancer Targeting NTRK1, NTRK2, NT NCT02097810	Hoffmann-La Roche	Phase 1
Completed	Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With NCT02045602	Theriva Biologics SL	Phase 1